Dolly Parton postpones her Las Vegas residency to 2026 for medical procedures, reassuring fans she is not retiring.
AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while the company's Enhertu drug shows promising results.
Dolly Parton postpones her Las Vegas residency to 2026 for medical procedures, reassuring fans she is not retiring.
AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while the company's Enhertu drug shows promising results.